2025 annual financial data
Zenas BioPharma 2025 Operating margin
Direct answer
Operating margin was -2,113.85%.
Operating income was -211,385,000 USD and net income was -377,737,000 USD.
Operating cash flow was -172,333,000 USD.
Get free Zenas BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -211,385,000 USD
- Net income
- -377,737,000 USD
- Operating cash flow
- -172,333,000 USD